FGFR1 and central nervous system cancer: All the point mutations in FGFR1 occurred in hotspot amino acids (p.Asn546Lys, p.Asn546Asp, p.Lys656Glu) that have previously been reported in many cancer types, including glioma and breast carcinoma [15].